Source: Health Canada shortage reports · Updated Jul 20, 2026
Some Pregabalin products are in shortage in Canada (17 of 79 reported products), while others remain available. Your pharmacy may be able to substitute an unaffected manufacturer. The latest estimate for affected products to return is May 16, 2027.
A nerve pain medication used to treat neuropathic pain and fibromyalgia.
Products affected
17 / 79
In shortage since
May 17, 2017
Est. full return
May 16, 2027
Reports on file
265
Talk to a pharmacist
Pharmacists can substitute an unaffected manufacturer's version, adjust strengths, and in most provinces adapt or renew a prescription on the spot.
Independent services, not affiliated with rxstat; referral fees may apply. Free options exist depending on your province. In an emergency call 911; free health advice at 811.
Shortage history
Shortage history (red bands = periods in shortage).
Reports by product
The DIN is printed on your prescription label.
Active shortage
TARO-PREGABALIN
25MG · CAPSULE · SUN PHARMA CANADA INC
DIN 02392801 · since Feb 11, 2026, est. end Aug 28, 2026 · Disruption of the manufacture of the drug.
Active shortage
TARO-PREGABALIN
50MG · CAPSULE · SUN PHARMA CANADA INC
DIN 02392828 · since Apr 17, 2026, est. end Aug 28, 2026 · Disruption of the manufacture of the drug.
Active shortage
NAT-PREGABALIN
225MG · CAPSULE · NATCO PHARMA (CANADA) INC
DIN 02494892 · since May 17, 2023, est. end May 16, 2027 · Long Term Back Order
Active shortage
ACH-PREGABALIN
50MG · CAPSULE · ACCORD HEALTHCARE INC
DIN 02449846 · since Feb 28, 2025, no end estimate · Requirements related to complying with good manufacturing practices.
Active shortage
APO-PREGABALIN
25MG · CAPSULE · APOTEX INC
DIN 02394235 · since May 7, 2024, no end estimate · Disruption of the manufacture of the drug.
Active shortage
APO-PREGABALIN
50MG · CAPSULE · APOTEX INC
DIN 02394243 · since Nov 12, 2024, no end estimate · Disruption of the manufacture of the drug.
Active shortage
APO-PREGABALIN
225MG · CAPSULE · APOTEX INC
DIN 02394286 · since Nov 12, 2024, no end estimate · Disruption of the manufacture of the drug.
Active shortage
APO-PREGABALIN
300MG · CAPSULE · APOTEX INC
DIN 02394294 · since Aug 20, 2024, no end estimate · Disruption of the manufacture of the drug.
Active shortage
APO-PREGABALIN
150MG · CAPSULE · APOTEX INC
DIN 02394278 · since Jul 16, 2024, no end estimate · Disruption of the manufacture of the drug.
Active shortage
APO-PREGABALIN
75MG · CAPSULE · APOTEX INC
DIN 02394251 · since Jul 16, 2024, no end estimate · Disruption of the manufacture of the drug.
Active shortage
ACH-PREGABALIN
150MG · CAPSULE · ACCORD HEALTHCARE INC
DIN 02449870 · since Jul 12, 2024, no end estimate · Requirements related to complying with good manufacturing practices.
Active shortage
ACH-PREGABALIN
225MG · CAPSULE · ACCORD HEALTHCARE INC
DIN 02449897 · since Jun 30, 2022, no end estimate · Disruption of the manufacture of the drug.
Showing 12 of 60 reports. All reports are on file with Health Canada.
What's happening
Pregabalin is currently affected by 17 active shortage reports filed with Health Canada by SUN PHARMA CANADA INC, NATCO PHARMA (CANADA) INC, ACCORD HEALTHCARE INC, APOTEX INC and 2 others.
The reported causes are: disruption of the manufacture of the drug; long term back order; requirements related to complying with good manufacturing practices; delay in shipping of the drug. Manufacturers must report shortages, but end-date estimates are their own projections and often move.
If your usual product is affected, a pharmacist is the fastest route to a solution: they can dispense an unaffected manufacturer's equivalent when one exists, and in most provinces can adapt doses or substitute a therapeutic alternative without a new appointment.
Recent changes
Jul 20, 2026
Shortage resolved
Jul 20, 2026
Shortage resolved
Jul 14, 2026
Shortage resolved
Jul 13, 2026
Estimated end date pushed back : Jun 26, 2026 → Jul 17, 2026
Jul 13, 2026
Shortage resolved
Jul 13, 2026
Estimated end date pushed back : Jul 3, 2026 → Jul 17, 2026
Common questions
What is Pregabalin used for?
A nerve pain medication used to treat neuropathic pain and fibromyalgia.
When will Pregabalin be back in stock in Canada?
The latest manufacturer estimate is May 16, 2027. Estimates are self-reported and often slip; this page updates automatically when they change.
Why is Pregabalin in shortage?
See the reports above; manufacturers must state a reason (most commonly manufacturing disruption or a surge in demand) when filing with Health Canada.
What can my pharmacist do about it?
Often quite a lot: substitute an equivalent product from an unaffected manufacturer, adjust quantities, or in most provinces adapt or renew prescriptions on the spot. Call your pharmacy before visiting, and call 811 for free health advice.
Email alerts
Get an email when this drug's status changes. Double opt-in, one-click unsubscribe.
Possible alternatives in the same class
Drugs in the same therapeutic class, best-supplied first. These are not automatic substitutes: only your pharmacist or prescriber can judge whether a switch makes sense for you.
Data reflects reports manufacturers are legally required to file with Health Canada, republished with per-drug aggregation by rxstat. Estimated end dates are supplied by manufacturers and frequently change. This page describes drug supply only and is not medical advice; never stop or switch a medication without speaking to your pharmacist or prescriber.